Últimas noticias:

Small-cap stocks can shine in a recession

Nov 23, 2023

Redacción Mapfre

Jonathan Boyar, director of Boyar Value Group and advisor to the MAPFRE AM US Forgotten Value Fund From a valuation standpoint, small-cap value shares are far and away the cheapest U.S. stocks. While large-cap growth shares (led by the Magnificent Seven group of tech stocks) are trading 36% above their 20-year average price/earnings multiple, JP Morgan reports that small-cap value is selling 14% below its 20-year average. The Russell 2000, a basket of smaller-cap companies, has been in a bear market since peaking in late 2021. It has since trailed the Russell 1000, which indexes larger-cap stocks, by about 20 full percentage points.

Many factors could help explain the short-term underperformance of small-cap shares, including rising interest rates, History suggests that leadership of the stock market could soon pass from large-caps to small-caps—especially if an economic slowdown lies ahead.

You can read the article here

High levels of debt and deficit threaten global growth

High levels of debt and deficit in many countries are among the main medium-term risks to the stability of the financial system. Both the financial system and the real economy may be impacted by public and private leverage aimed at sustaining dynamism, as detailed in the report “Economic and Sectoral Outlook 2024: Prospects for the Second Half of the Year,” by MAPFRE Economics.

How to buy the Knicks and the Rangers 50% off

Madison Square Garden Sports Corp. (NYSE: MSGS) owns two of the most iconic franchises in the world of sports: the New York Knicks and the New York Rangers. Over the past 4 years, the value of the Knicks and Rangers as estimated by Forbes have increased by 65% and 61%, respectively, but despite this substantial increase, MSGS’s shares have increased by a meager 26%.

These are the two scenarios for the global economy envisaged by MAPFRE Economics

The past few years have been shaped by uncertainty. That’s why MAPFRE Economics, MAPFRE’s research arm, always considers two different scenarios in its report “2024 Economic and Industry Outlook: Second Quarter Perspectives.”